Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03626038 · ClinicalTrials.gov registry record · NA

Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
135
Enrollment target
7
Study locations

NCT03626038 is a NA study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 135 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03626038, a NA study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
135 participants
Enrollment target
7
Study locations

Study Summary

This study is a multicenter, prospective, non-randomized, non-controlled post-market clinical follow-up study. The primary objective of this study is to confirm the safety and performance of the A.L.P.S. Proximal Humerus Plating System applied in proximal humerus fracture treatment.

Conditions Studied

Rheumatoid Arthritis Osteoarthritis Psoriatic Arthritis Post Traumatic Arthritis Proximal Humeral Fracture

Interventions

  • DEVICE A.L.P.S. Proximal Humerus Plating System

Study Locations (7)

Seoul

  • Korea University Anam Hospital - Seoul
  • Hallym University Kangnam Sacred Hearth Hospital - Seoul
  • Inje University Seoul Paik Hospital - Seoul

Florida

  • Foundation for Orthopaedic Research & Education - Tampa

New South Wales

  • Sydney Adventist Hospital - Wahroonga

Quebec

  • The Research Institute of McGill University Health Centre - Montreal

Granges-Paccot

  • Bone and Motion Training and Research Foundation - Granges-Paccot

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2018-06-19
Est. Completion 2026-12
Phase NA

Sponsor

Zimmer Biomet

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03626038

The ClinicalTrials.gov registry entry for NCT03626038 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which A.L.P.S. Proximal Humerus Plating System is the first listed.

NCT03626038 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Seoul, Florida, New South Wales.

Frequently Asked Questions

What is clinical trial NCT03626038 about?

NCT03626038 is a clinical study titled "Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System". This study is a multicenter, prospective, non-randomized, non-controlled post-market clinical follow-up study. The primary objective of this study is to confirm the safety and performance of the A.L.P.S. Proximal Humerus Plating System applied in proximal humerus fracture treatment.

What is the current status of trial NCT03626038?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2018-06-19. Estimated completion is 2026-12.

What conditions does trial NCT03626038 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Post Traumatic Arthritis, Proximal Humeral Fracture.

What interventions are being tested in trial NCT03626038?

The interventions under investigation include: A.L.P.S. Proximal Humerus Plating System (DEVICE).

Who is sponsoring clinical trial NCT03626038?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03626038 being conducted?

This trial has 7 study locations across Florida, New South Wales, Quebec, Seoul, Granges-Paccot. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Osteoarthritis

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.